A20 inhibits post-angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularization

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 404-408

  Damrauer, Scott M ^a,c   Fisher, Mark D ^a   Wada, Hiromi ^b   Siracuse, Jeffrey J ^a   da Silva, Cleide G ^a   Moon, Karam ^a   Csizmadia, Eva ^a   Maccariello, Elizabeth R ^a   Patel, Virendra I ^a   Studer, Peter ^a   Essayagh, Sanah ^a   Aird, William C ^b   Daniel, Soizic ^a   Ferran, Christiane ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Macrophage; Neointimal hyperplasia; Neovascularization; Vascular endothelial growth factor

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN A20; UNCLASSIFIED DRUG; VASCULOTROPIN; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR GENE THERAPY; CAROTID ANGIOPLASTY; CAROTID ARTERY INJURY; CELL HOMING; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN-STENT RESTENOSIS; MACROPHAGE MIGRATION INHIBITION; MALE; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; DNA-BINDING PROTEINS; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; HUMANS; HYPERPLASIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MALE; MONOCYTES; NEOINTIMA; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77955273317     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.029     Document Type: Article

References (30)

1. Bourcier T., Sukhova G., Libby P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 1997, 272:15817-15824.
2. Zuckerbraun B.S., McCloskey C.A., Mahidhara R.S., et al. Overexpression of mutated I[kappa]B[alpha] inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation. J Vasc Surg 2003, 38:812-819.
3. Shintani T., Sawa Y., Takahashi T., et al. Intraoperative transfection of vein grafts with the NFkappaB decoy in a canine aortocoronary bypass model: a strategy to attenuate intimal hyperplasia. Ann Thorac Surg 2002, 74:1132-1137. discussion 1137-1138.
4. Yoshimura S., Morishita R., Hayashi K., et al. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy. Gene Ther 2001, 8:1635-1642.
5. Squadrito F., Deodato B., Bova A., et al. Crucial role of nuclear factor-kappaB in neointimal hyperplasia of the mouse carotid artery after interruption of blood flow. Atherosclerosis 2003, 166:233-242.
6. Patel V.I., Daniel S., Longo C.R., et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia. FASEB J 2006, 20:1418-1430.
7. Wang A.B., Li H.L., Zhang R., et al. A20 attenuates vascular smooth muscle cell proliferation and migration through blocking PI3k/Akt singling in vitro and in vivo. J Biomed Sci 2007, 14:357-371.
8. Kwon H.M., Sangiorgi G., Ritman E.L., et al. Adventitial vasa vasorum in balloon-injured coronary arteries: visualization and quantitation by a microscopic three-dimensional computed tomography technique. J Am Coll Cardiol 1998, 32:2072-2079.
9. Kwon H.M., Sangiorgi G., Ritman E.L., et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest 1998, 101:1551-1556.
10. Westerband A., Gentile A.T., Hunter G.C., et al. Intimal growth and neovascularization in human stenotic vein grafts. J Am Coll Surg 2000, 191:264-271.
11. Barleon B., Sozzani S., Zhou D., et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996, 87:3336-3343.
12. Kim I., Moon S.O., Kim S.H., et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001, 276:7614-7620.
13. Grosskreutz C.L., Anand-Apte B., Duplaa C., et al. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 1999, 58:128-136.
14. Moore M.A., Hattori K., Heissig B., et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann N Y Acad Sci 2001, 938:36-45. discussion 45-37.
15. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
16. Ferran C., Stroka D.M., Badrichani A.Z., et al. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 1998, 91:2249-2258.
17. Clowes A.W., Reidy M.A., Clowes M.M. Mechanisms of stenosis after arterial injury. Lab Invest 1983, 49:208-215.
18. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 1962, 115:453-466.
19. Koga T., Claycombe K., Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 2002, 161:365-374.
20. Daniel S., Patel V.I., Shrikhande G.V., et al. The universal NF-kappaB inhibitor a20 protects from transplant vasculopathy by differentially affecting apoptosis in endothelial and smooth muscle cells. Transplant Proc 2006, 38:3225-3227.
21. Nelken N.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991, 88:1121-1127.
22. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991, 88:5252-5256.
23. Tatewaki H., Egashira K., Kimura S., et al. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation. J Vasc Surg 2007, 45:1236-1243.
24. Nakano K., Egashira K., Ohtani K., et al. Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeys. Atherosclerosis 2007, 194:309-316.
25. Suzuki J., Izawa A., Isobe M. Anti-vascular cell adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies inhibit neointimal hyperplasia in the murine model of arterial injury. Acta Cardiol 2004, 59:147-152.
26. Inoue M., Itoh H., Ueda M., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998, 98:2108-2116.
27. Shibata M., Suzuki H., Nakatani M., et al. The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation. Histochem Cell Biol 2001, 116:471-481.
28. Ohtani K., Egashira K., Hiasa K., et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 2004, 110:2444-2452.
29. Marumo T., Schini-Kerth V.B., Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999, 48:1131-1137.
30. Stefanadis C., Toutouzas K., Stefanadi E., et al. Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: an experimental study. Atherosclerosis 2007, 195:269-276.